Organogenesis Statistics Share Statistics Organogenesis has 126.85M
shares outstanding. The number of shares has increased by -4.32%
in one year.
Shares Outstanding 126.85M Shares Change (YoY) -4.32% Shares Change (QoQ) 0.02% Owned by Institutions (%) 51.09% Shares Floating 64.15M Failed to Deliver (FTD) Shares 2,820 FTD / Avg. Volume 0.29%
Short Selling Information The latest short interest is 9.73M, so 7.67% of the outstanding
shares have been sold short.
Short Interest 9.73M Short % of Shares Out 7.67% Short % of Float 22.31% Short Ratio (days to cover) 9.63
Valuation Ratios The PE ratio is 489.38 and the forward
PE ratio is 22.62.
Organogenesis's PEG ratio is
-3.87.
PE Ratio 489.38 Forward PE 22.62 PS Ratio 0.87 Forward PS 1 PB Ratio 1.09 P/FCF Ratio 100.9 PEG Ratio -3.87
Financial Ratio History Enterprise Valuation Organogenesis has an Enterprise Value (EV) of 329.1M.
EV / Sales 0.68 EV / EBITDA 20.88 EV / EBIT 23.16 EV / FCF 78.81
Financial Position The company has a current ratio of 3.69,
with a Debt / Equity ratio of 0.11.
Current Ratio 3.69 Quick Ratio 3.35 Debt / Equity 0.11 Debt / EBITDA 2.75 Debt / FCF 10.37 Interest Coverage -0.83
Financial Efficiency Return on Equity is 0.22% and Return on Invested Capital is 0.09%.
Return on Equity 0.22% Return on Assets 0.17% Return on Invested Capital 0.09% Revenue Per Employee $554.71K Profits Per Employee $990.79 Employee Count 869 Asset Turnover 0.97 Inventory Turnover 4.41
Taxes Income Tax -3.67M Effective Tax Rate 130.67%
Stock Price Statistics The stock price has increased by 90.5% in the
last 52 weeks. The beta is 1.77, so Organogenesis's
price volatility has been higher than the market average.
Beta 1.77 52-Week Price Change 90.5% 50-Day Moving Average 3.93 200-Day Moving Average 3.86 Relative Strength Index (RSI) 54.06 Average Volume (20 Days) 965,608
Income Statement In the last 12 months, Organogenesis had revenue of 482.04M
and earned 861K
in profits. Earnings per share was -0.01.
Revenue 482.04M Gross Profit 366.3M Operating Income -1.28M Net Income 861K EBITDA 15.76M EBIT -1.26M Earnings Per Share (EPS) -0.01
Full Income Statement Balance Sheet The company has 135.57M in cash and 43.31M in
debt, giving a net cash position of 92.26M.
Cash & Cash Equivalents 135.57M Total Debt 43.31M Net Cash 92.26M Retained Earnings -40.11M Total Assets 467.39M Working Capital 203.11M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 14.21M
and capital expenditures -10.03M, giving a free cash flow of 4.18M.
Operating Cash Flow 14.21M Capital Expenditures -10.03M Free Cash Flow 4.18M FCF Per Share 0.03
Full Cash Flow Statement Margins Gross margin is 75.99%, with operating and profit margins of -0.27% and 0.18%.
Gross Margin 75.99% Operating Margin -0.27% Pretax Margin -0.58% Profit Margin 0.18% EBITDA Margin 3.27% EBIT Margin -0.27% FCF Margin 0.87%
